Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
Queensland Health
Fuji
Deloitte
Citi
AstraZeneca
Daiichi Sankyo
Accenture

Generated: April 25, 2018

DrugPatentWatch Database Preview

CEFIZOX Drug Profile

« Back to Dashboard

Which patents cover Cefizox, and when can generic versions of Cefizox launch?

Cefizox is a drug marketed by Astellas and is included in three NDAs.

The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
Drug patent expirations by year for CEFIZOX
Medical Subject Heading (MeSH) Categories for CEFIZOX
Synonyms for CEFIZOX
(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt
26337D5X88
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2,3-dihydro-2-imino-4-thiazoly)(methoxyimino)acetyl]amino]-8-oxomonosodium salt
68401-81-0 (Parent)
68401-82-1
AB0013203
AB09741
AB1009513
AC-5544
ADLFUPFRVXCDMO-LIGXYSTNSA-M
AKOS015895385
AKOS015951359
AKOS015963314
AKOS025392168
AKOS025402140
AN-10905
C08118
CAS-68401-82-1
Cefizox (TN)
CEFIZOX IN PLASTIC CONTAINER
Ceftizoxim-natrium
Ceftizoxime (sodium)
CEFTIZOXIME SODIUM
Ceftizoxime sodium (JP17/USP)
Ceftizoxime sodium [USAN:USP:JAN]
Ceftizoxime sodium salt
Ceftizoxime sodium salt, Antibiotic for Culture Media Use Only
Ceftizoximesodium
CHEBI:3512
CHEMBL1201019
CS-5309
CZX
D00923
DR002396
DSSTox_CID_26643
DSSTox_GSID_46643
DSSTox_RID_81789
DTXSID5046643
Epocelin
Epocelin (TN)
Eposerin
FK 749
FR-13
H711
HE379538
HY-B1596A
I06-0633
KS-1417
MolPort-006-823-796
MolPort-035-783-494
NCGC00167460-01
SCHEMBL41003
SK&F 88373-Z
SK&F-88373-Z
SK&F-88373Z
sodium (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylate
ST51052804
Tox21_112464
UNII-26337D5X88
W-2956

US Patents and Regulatory Information for CEFIZOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas CEFIZOX ceftizoxime sodium INJECTABLE;INJECTION 063294-002 Mar 31, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astellas CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-001 Oct 3, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astellas CEFIZOX ceftizoxime sodium INJECTABLE;INJECTION 050560-003 Sep 15, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astellas CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-002 Oct 3, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Cantor Fitzgerald
Deloitte
Farmers Insurance
Mallinckrodt
Chinese Patent Office
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.